The FDA is warning healthcare professionals and pharmacies to avoid using Hospira's unapproved potassium phosphates product in pediatric patients due to the potential for aluminum exposure up to 2x the FDA-recommended limits for PN. Read the pdf for the full FDA warning.
Phosphate products in US - 2023-02-09
.pdf
UploadFile_Viewer_Download